Diane F Jelinek, PhD

  • 10471 Citations
  • 60 Scopus h-Index
1981 …2020
If you made any changes in Pure, your changes will be visible here soon.

Projects 1989 2020

Active
Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance
Disease Progression
Neoplasms
Plasma Cells
Finished
Long Noncoding RNA
B-Cell Chronic Lymphocytic Leukemia
Untranslated RNA
Immunoglobulin Heavy Chains
Proteins
Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Glycolysis
Plasma Cells
Neoplasms
Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Biomarkers
Plasma Cells
Tumor Microenvironment
B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Immunoglobulin Heavy Chains
B-Cell Antigen Receptors
Cell Survival
B-Cell Activating Factor
Plasma Cells
B-Cell Maturation Antigen
Ligands
B-Lymphocytes

STUDIES OF MONOCLONAL GAMMOPATHIES

Therneau, T. M., Rajkumar, S. V., Jelinek, D. F., Witzig, T. E., Therneau, T. M., O'Fallon, W., O'Fallon, W. M., O'Fallon, W., Last, J., O'Fallon, W. M., van Ness, B., Kyle, R., Fonsecar, R., Greipp, P., Lust, J. A. & Michael O'Fallon, W.

National Institutes of Health

9/30/941/31/11

Project: Research project

Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Paraproteinemias
Epidemiology
Biostatistics
Interleukin-6
IGF Type 1 Receptor
Insulin-Like Growth Factor I
Plasma Cells
Cell Proliferation